USPTO serial 75178758
PHARMAPRINT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SARAI, BALDEV
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHARMAPRINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
EUGENE K HYUN
EUGENE K HYUN LYON & LYON LLP633 W 5TH ST STE 4700LOS ANGELES, CA 90071-2066UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce the symptoms of premenstrual stress (pms), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the respiratory and urinary tracts; promote the flow in menstruation and reduce cramping pain; reduce certain types of skin outbreaks (eczema), reduce the pain of migraine headaches and menstrual periods, and are used in the treatment of asthma and arthritis; breakdown of blood clots; reduce nausea by acting on the digestive tract; and of abnormal changes in the light sensing portion of the eye, i.e., retina; reduce stress and damage caused to the liver; are used in the treatment of cancer; and are a general tonic; reduce cramping pain, muscle and joint pain; heart conditions associated with the elderly, mild heart pain brought on by exertion (angina), and mild irregularities of the heart beat; and lower blood pressure; are used in the treatment of degenerative arthritis; reduce distress of the intestinal tract; and improve the clearing of mucus from the lungs; cause sleepiness and treats insomnia; are used in the treatment of ulcers and arthritis; reduce inflammation; and improve the clearing of mucus from the lungs; protect the liver, including against scarring (cirrhosis) and inflammation (hepatitis); are a free radical scavenger and antioxidant; reduce pain and inflammation and improve insomnia and bronchial asthma; are used in the treatment of cancer and diabetes; and in some ways act like an antioxidant; have an effect against cancer; lower blood pressure; help protect a developing fetus against damage from exposure of drugs, chemicals and certain other materials; help the body remove excess fluid through urination; are used in the treatment of asthma; improve rheumatism; and stimulate the growth of hair; promote sleepiness; calm; modify the activity of the body's immune system; and reduce elevated levels of certain fatty substances in the blood; treat cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 2, 2002 | PAPER RECEIVED | — | |
| Apr 17, 2001 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 29, 2000 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 19, 2000 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 6, 1999 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 19, 1999 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 3, 1999 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 19, 1999 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 20, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| May 12, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 1997 | DOCK | ASSIGNED TO EXAMINER | — |